Articles

Evaluating bioreactor turndown ratios in high-density perfusion

One bioreactor that handles both seed expansion and high-density production reduces facility capital, simplifies qualification, and compresses the seed train. Turndown ratio is the specification that makes it possible.
Written byTrevor J Henderson
| 5 min read
A single-use bioreactor running at a fraction of its maximum working volume, illustrating the high turndown ratio concept in which one vessel serves as both seed train and production bioreactor.

A bioreactor running at 10% of its maximum working volume during a perfusion seed culture phase can be inoculated at full volume for the production run without changing vessels. That is what a 10:1 turndown ratio makes possible, and why it is one of the most valuable specifications for process intensification facility design.

Flow (2026)

Register for free to listen to this article
Listen with Speechify
0:00
5:00

A bioreactor with a 10:1 turndown ratio can run a perfusion seed culture at 200 liters and a full fed-batch production run at 2,000 liters in the same vessel. Eliminating the dedicated N-1 seed bioreactor removes one qualified vessel, one CIP/SIP system, and weeks from the facility commissioning timeline. For process intensification programs targeting smaller seed trains and higher inoculation density, turndown ratio is among the most consequential vessel specifications on the equipment list.

Key takeaways

  • Turndown ratio is the ratio of a bioreactor's maximum to minimum working volume. A 10:1 ratio means the vessel can operate at 200 liters and 2,000 liters within the same hardware platform.
  • High-density perfusion specifically requires high-turndown vessels. Perfusion seed cultures start at minimum volume and accumulate cell mass over days; only a high-turndown vessel can seed the production run from that same vessel at a 10:1 or greater expansion ratio.
  • The engineering challenge of high turndown is maintaining adequate kLa, mixing, and pH control at minimum working volume, where impeller immersion depth, headspace gas management, and sparger performance all differ significantly from maximum volume conditions.
  • Qualification scope for a dual-purpose vessel must cover both the minimum and maximum working volume operating ranges. A qualification package based only on maximum volume does not support GMP operation at minimum volume.
  • N-1 perfusion programs in particular should evaluate turndown ratio as a primary selection criterion, since the N-1 vessel must perform as both a stable perfusion seed culture environment and the inoculum source for a much larger production bioreactor.

For the seed train architecture context in which turndown ratio decisions are made, see the blueprint for single-use biomanufacturing facilities. For the N-1 perfusion engineering and inoculation density outcomes that depend on seed vessel performance, see the engineering behind seamless bioreactor scale-up.

What is bioreactor turndown ratio and why does it matter for perfusion?

Turndown ratio is the ratio of a bioreactor's maximum working volume to its minimum working volume. A vessel rated for a maximum of 2,000 liters with a minimum working volume of 200 liters has a 10:1 turndown ratio. Standard stirred-tank bioreactors are typically designed for turndown ratios of 3:1 to 5:1, meaning the vessel can operate from 33% to 50% of its maximum volume at minimum. High-density perfusion programs require more.

In a perfusion-based seed train, the N-1 bioreactor starts culture at a small initial volume, feeds continuously while cells accumulate, and delivers a high-density inoculum to the production bioreactor at the end of the seed phase. If the same vessel is then used for the production run, the volume transition from seed phase to production phase may represent a 10:1 or greater expansion, a transition that only a high-turndown vessel can execute without introducing the production bioreactor as a separate piece of equipment.

Continue reading below...
3D illustration of a membrane protein embedded within a lipid nanodisc, representing a native-like environment used for membrane protein stabilization and characterization.
Application NoteCharacterizing nanodisc-embedded membrane proteins
Mass photometry supports membrane protein characterization by providing rapid insights into sample composition, purity, and molecular assembly.
Read More

The regulatory framework for perfusion-based continuous and intensified manufacturing is provided by ICH Q13: Continuous Manufacturing of Drug Substances and Drug Products, adopted in 2023. ICH Q13 explicitly addresses perfusion bioreactor systems, continuous seed trains, and the control strategy considerations required to demonstrate process understanding across the full operating range of a dual-purpose vessel. A 2025 study from Polytechnique Montreal and the National Research Council Canada demonstrated that ultra-high seeding density inoculation from N-1 semi-continuous perfusion significantly shortens the production bioreactor growth phase and improves space-time yield, confirming the productivity case for high-turndown dual-purpose vessel designs.

For standard fed-batch seed trains, a 5:1 turndown is often sufficient. For N-1 perfusion programs targeting inoculation at 2 to 10 million cells per milliliter into the production bioreactor, turndown ratios of 10:1 or greater allow the seed culture and the production run to occur in the same vessel with no hardware change between phases.

The hydrodynamic challenge of operating across a wide volume range

Mixing and oxygen transfer at minimum working volume

The hydrodynamic environment inside a stirred-tank bioreactor changes significantly as working volume decreases. At minimum working volume, the impeller may be partially exposed above the liquid surface depending on vessel geometry; gassing through the submerged sparger produces a disproportionately large bubble column relative to liquid depth, and the surface-to-volume ratio increases, changing the rate of oxygen and CO2 exchange at the liquid surface. All of these factors must be characterized and managed through process control adjustments to ensure that cell culture conditions at minimum volume are equivalent to those at maximum volume.

kLa, the oxygen transfer coefficient that must remain above the culture's oxygen demand at all viable cell densities, typically decreases at minimum working volume for a given agitation speed because the liquid depth above the sparger is reduced. Process engineers designing high-turndown perfusion protocols must confirm that the control strategy for agitation rate and gas flow rate at minimum volume delivers adequate kLa for the cell density and specific oxygen uptake rate at each phase of the seed culture.

Turndown ratio options and their seed train implications

The table below shows how different turndown ratios map to typical dual-purpose seed train and production configurations, and the practical seed train vessel count implications of each.

Turndown ratio

Min working volume

Seed train use case

Seed train stages replaced

3:1

33% of maximum

Standard fed-batch N-1 followed by full-volume fed-batch production

None; standard configuration

5:1

20% of maximum

Small-scale N-1 fed-batch seed followed by production at maximum volume

Potentially one small seed stage for high-inoculation programs

10:1

10% of maximum

N-1 perfusion seed at 10% of vessel volume followed by full production run; one vessel replaces two

One dedicated N-1 seed bioreactor eliminated from the seed train

20:1 or greater

5% of maximum

Ultra-high inoculation density programs; minimal N-1 volume requires highly robust mixing and gas transfer at low volume

One to two dedicated seed stages potentially eliminated; qualification complexity increases proportionally

How does a dual-purpose vessel change facility qualification scope?

A vessel that serves as both N-1 seed bioreactor and production bioreactor requires qualification data at both operating volume ranges. An IQ/OQ/PQ package developed only for the maximum working volume does not support GMP operation of the same vessel at 10% or 20% of that volume. Process engineers must confirm kLa, mixing time, pH control response, and temperature uniformity data at both the minimum seed volume and the maximum production volume before either use is covered by the qualification record.

The regulatory expectation is that every GMP operating condition of a bioreactor be demonstrated to perform within specification before GMP use. Operating a high-turndown vessel at minimum volume for N-1 perfusion without qualification data at that volume is a compliance gap. For the qualification framework applicable to dual-purpose bioreactor systems in a GMP context, see Lab Manager's guide to IQ/OQ/PQ equipment qualification in bioprocessing.

What specifications should engineers prioritize when evaluating turndown ratio?

When evaluating single-use bioreactors for high-density perfusion with dual-purpose seed and production function, the following specifications should be assessed alongside turndown ratio:

  • Minimum kLa at minimum working volume: confirmed by the supplier or by in-house characterization; must exceed the maximum specific oxygen uptake rate expected at peak N-1 viable cell density
  • Mixing time at minimum working volume: longer mixing times at low volume increase the risk of pH and DO heterogeneity during base addition and feeding; should be characterized against the maximum expected base pulse volume
  • Impeller design at minimum volume: impeller geometry appropriate for the minimum volume operating condition; partial impeller immersion at minimum volume can cause vortexing and shear damage
  • Control system capability: the bioreactor control system must manage independent parameter control across the full volume range; some single-use control systems have minimum volume constraints not reflected in the turndown ratio specification
  • Bag integrity across the volume range: single-use bags must maintain integrity and mixing geometry across the full volume range; bag film rigidity and support structure affect performance at extreme low and high volume conditions

This article was produced under Drug Discovery News' AI Editorial Guidelines.

Frequently Asked Questions (FAQs)

  • What is turndown ratio in a bioreactor?

    Turndown ratio is the ratio of a bioreactor's maximum to minimum working volume. A vessel rated for 2,000 liters maximum with a 200-liter minimum working volume has a 10:1 turndown ratio. Standard bioreactors typically have 3:1 to 5:1 turndown ratios. High-density perfusion programs that use the same vessel for seed train and production require 10:1 or greater turndown to accommodate both the small initial perfusion seed volume and the full production volume in the same hardware.

  • Why does high-density perfusion require a higher turndown ratio than fed-batch?

    High-density perfusion seed cultures start at a small working volume and accumulate cell mass over time through continuous media exchange, reaching viable cell densities of 20 to 80 million cells per milliliter in the N-1 vessel before inoculating the production bioreactor. If the same vessel is used for the subsequent production run, the volume transition from seed phase to production phase may be 10-fold or greater. A 3:1 or 5:1 turndown vessel cannot accommodate this transition without an intermediate vessel change. Only a 10:1 or greater turndown vessel can serve both functions in sequence.

  • What are the key engineering challenges of operating a bioreactor at its minimum working volume?

    At minimum working volume, the bioreactor hydrodynamics differ significantly from maximum volume conditions. The oxygen transfer coefficient (kLa) is typically lower at minimum volume for a given agitation and gassing rate, because the liquid depth above the sparger is reduced. Mixing time may be disproportionately longer or shorter depending on impeller immersion depth. pH control response to base addition is more abrupt because the smaller liquid volume has less buffer capacity. All of these behaviors must be characterized and confirmed through qualification testing at the minimum working volume before GMP operation at that volume is permitted.

  • Does a dual-purpose vessel require separate IQ/OQ/PQ for each working volume?

    Qualification of a dual-purpose bioreactor must cover both the minimum working volume (for the N-1 perfusion seed phase) and the maximum working volume (for the production phase). A qualification package based only on the maximum working volume does not provide the documented evidence that the vessel performs within specification at minimum volume. In practice, OQ testing at a minimum of the minimum and maximum working volumes, with process characterization data confirming kLa, mixing performance, and control system behavior at each, provides the qualification basis for dual-purpose GMP operation.

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

About the Author

  • Drug Discovery News Placeholder Image

    Trevor Henderson is the Creative Services Director for the Laboratory Products Group at LabX Media Group. With over two decades of experience, he specializes in scientific and technical writing, editing, and content creation. His academic background includes training in human biology, physical anthropology, and community health. Since 2013, he has been developing content to engage and inform scientists and laboratorians.

    View Full Profile

Here are some related topics that may interest you:

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

3D illustration of a membrane protein embedded within a lipid nanodisc, representing a native-like environment used for membrane protein stabilization and characterization.
Mass photometry supports membrane protein characterization by providing rapid insights into sample composition, purity, and molecular assembly.
3D illustration of a protein complex composed of clustered spherical subunits arranged in a ring-like oligomeric structure, shown in shades of blue, cyan, and purple against a blue gradient background.
Automated mass photometry helps reveal the complex dynamics of protein oligomerization and the factors that govern protein assembly.
Illustration of translucent Y-shaped antibodies floating in a soft blue and green background, representing antibody research, development, and biomedical science.
Explore how antibody accessibility and custom development strategies can influence the pace and success of translational research.
Drug Discovery News December 2025 Issue
Latest IssueVolume 21 • Issue 4 • December 2025

December 2025

December 2025 Issue

Explore this issue